Charles J Homcy - Net Worth and Insider Trading

Charles J Homcy Net Worth

The estimated net worth of Charles J Homcy is at least $44 Million dollars as of 2024-05-12. Charles J Homcy is the Chairman of Pharmaceuticals of BridgeBio Pharma Inc and owns about 1,203,767 shares of BridgeBio Pharma Inc (BBIO) stock worth over $35 Million. Charles J Homcy is the Director of Global Blood Therapeutics Inc and owns about 69,328 shares of Global Blood Therapeutics Inc (GBT) stock worth over $5 Million. Charles J Homcy is also the Director of Portola Pharmaceuticals Inc and owns about 251,951 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $5 Million. Details can be seen in Charles J Homcy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles J Homcy has not made any transactions after 2020-10-16 and currently still holds the listed stock(s).

Transaction Summary of Charles J Homcy

To

Charles J Homcy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles J Homcy owns 9 companies in total, including BridgeBio Pharma Inc (BBIO) , Pliant Therapeutics Inc (PLRX) , and Portola Pharmaceuticals Inc (PTLA) among others .

Click here to see the complete history of Charles J Homcy’s form 4 insider trades.

Insider Ownership Summary of Charles J Homcy

Ticker Comapny Transaction Date Type of Owner
BBIO BridgeBio Pharma Inc 2020-10-16 director & Chairman of Pharmaceuticals
PLRX Pliant Therapeutics Inc 2020-06-02 director
PTLA Portola Pharmaceuticals Inc 2019-03-28 other: Former Director
2017-10-27 director
2016-11-29 director
2005-07-15 director
2005-05-19 director
2020-11-17 director
2020-11-17 director

Charles J Homcy Latest Holdings Summary

Charles J Homcy currently owns a total of 3 stocks. Among these stocks, Charles J Homcy owns 1,203,767 shares of BridgeBio Pharma Inc (BBIO) as of October 16, 2020, with a value of $35 Million and a weighting of 79.04%. Charles J Homcy owns 69,328 shares of Global Blood Therapeutics Inc (GBT) as of October 27, 2017, with a value of $5 Million and a weighting of 10.71%. Charles J Homcy also owns 251,951 shares of Portola Pharmaceuticals Inc (PTLA) as of December 17, 2018, with a value of $5 Million and a weighting of 10.25%.

Latest Holdings of Charles J Homcy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BBIO BridgeBio Pharma Inc 2020-10-16 1,203,767 29.10 35,029,620
GBT Global Blood Therapeutics Inc 2017-10-27 69,328 68.49 4,748,275
PTLA Portola Pharmaceuticals Inc 2018-12-17 251,951 18.03 4,542,677

Holding Weightings of Charles J Homcy


Charles J Homcy Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles J Homcy has made a total of 5 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 10,256 shares on October 16, 2020, which brought Charles J Homcy around $420,496.

According to the SEC Form 4 filings, Charles J Homcy has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 70,000 shares on October 27, 2017, which brought Charles J Homcy around $2 Million.

According to the SEC Form 4 filings, Charles J Homcy has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 64,218 shares on December 17, 2018, which brought Charles J Homcy around $1 Million.

Insider Trading History of Charles J Homcy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles J Homcy Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles J Homcy Ownership Network

Ownership Network List of Charles J Homcy

No Data

Ownership Network Relation of Charles J Homcy


Charles J Homcy Owned Company Details

What does BridgeBio Pharma Inc do?

Who are the key executives at BridgeBio Pharma Inc?

Charles J Homcy is the director & Chairman of Pharmaceuticals of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include Chairman of Oncology Frank Mccormick , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .

BridgeBio Pharma Inc (BBIO) Insider Trades Summary

Over the past 18 months, Charles J Homcy made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 1,034,094 shares made by Neil Kumar , a net sale of 412,388 shares made by Brian C Stephenson , and a net sale of 9,500 shares made by Randal W Scott .

In summary, during the past 3 months, insiders sold 2,500 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 3,064,727 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,064,727 shares.

BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BridgeBio Pharma Inc Insider Transactions

No Available Data

Charles J Homcy Mailing Address

Above is the net worth, insider trading, and ownership report for Charles J Homcy. You might contact Charles J Homcy via mailing address: Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco Ca 94080.

Discussions on Charles J Homcy

No discussions yet.